B. Wadman

887 total citations
28 papers, 472 citations indexed

About

B. Wadman is a scholar working on Genetics, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, B. Wadman has authored 28 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 7 papers in Physiology and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in B. Wadman's work include Acute Lymphoblastic Leukemia research (6 papers), Erythrocyte Function and Pathophysiology (5 papers) and Neutropenia and Cancer Infections (4 papers). B. Wadman is often cited by papers focused on Acute Lymphoblastic Leukemia research (6 papers), Erythrocyte Function and Pathophysiology (5 papers) and Neutropenia and Cancer Infections (4 papers). B. Wadman collaborates with scholars based in Sweden, United Kingdom and Denmark. B. Wadman's co-authors include L Juhlin, Ivar Werner, L. Engstedt, Lars‐Eric Bratteby, Lars Garby, A. Killander, Werner Schneider, Torgny Groth, Anders Gamstedt and Peter Reizenstein and has published in prestigious journals such as New England Journal of Medicine, The Lancet and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

B. Wadman

26 papers receiving 401 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Wadman Sweden 13 148 133 94 70 59 28 472
P. D. Roberts United Kingdom 17 157 1.1× 206 1.5× 63 0.7× 72 1.0× 29 0.5× 24 547
S. C. Tso China 13 162 1.1× 192 1.4× 79 0.8× 34 0.5× 17 0.3× 24 473
Sheryl R. Simon United States 11 70 0.5× 166 1.2× 86 0.9× 64 0.9× 64 1.1× 15 462
Franco Capra Italy 15 95 0.6× 240 1.8× 65 0.7× 39 0.6× 43 0.7× 43 879
Barry G. Firkin Australia 17 84 0.6× 404 3.0× 102 1.1× 54 0.8× 30 0.5× 44 749
Irving B. Mink United States 14 63 0.4× 167 1.3× 113 1.2× 40 0.6× 143 2.4× 25 639
Karin L. G. Svenson Sweden 12 72 0.5× 71 0.5× 50 0.5× 41 0.6× 30 0.5× 17 623
E. Cutz Canada 15 109 0.7× 127 1.0× 209 2.2× 19 0.3× 44 0.7× 23 742
Michel-Henry Mendler France 7 159 1.1× 214 1.6× 60 0.6× 56 0.8× 46 0.8× 9 654
Pamela B. Sylvestre United States 13 128 0.9× 129 1.0× 133 1.4× 112 1.6× 35 0.6× 27 882

Countries citing papers authored by B. Wadman

Since Specialization
Citations

This map shows the geographic impact of B. Wadman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Wadman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Wadman more than expected).

Fields of papers citing papers by B. Wadman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Wadman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Wadman. The network helps show where B. Wadman may publish in the future.

Co-authorship network of co-authors of B. Wadman

This figure shows the co-authorship network connecting the top 25 collaborators of B. Wadman. A scholar is included among the top collaborators of B. Wadman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Wadman. B. Wadman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brodin, Hå̊kan, et al.. (1994). Cost analysis of different phases of acute myeloid leukaemia. Leukemia Research. 18(10). 783–790. 18 indexed citations
2.
Wadman, B., et al.. (1993). Assessing Quality of Life in Leukemia: Presentation of an Instrument for Assessing Quality of Life in Patients with Blood Malignancies. International Journal for Quality in Health Care. 5(3). 201–211. 12 indexed citations
3.
Wadman, B., et al.. (1993). Evaluación de la Calidad de Vida en la Leucemia: Presentación de un Instrumento para Evaluar la Calidad de Vida de los Pacientes con Hemopatías Malignas. International Journal for Quality in Health Care. 5(3). 275–275. 1 indexed citations
4.
Gamstedt, Anders, B. Wadman, & Anders Karlsson. (1986). Methimazole, but not Betamethasone, Prevents131I Treatment-Induced Rises in Thyrotropin Receptor Autoantibodies in Hyperthyroid Graves' Disease*. The Journal of Clinical Endocrinology & Metabolism. 62(4). 773–777. 25 indexed citations
5.
Kimby, Eva, Magnus Björkholm, Håkan Mellstedt, et al.. (1982). Treatment of chronic lymphocytic leukaemia and well-differentiated lymphocytic lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil/prednisolone. European Journal of Cancer and Clinical Oncology. 18(11). 1117–1123. 50 indexed citations
6.
Engstedt, L., Robert Hast, G. Holm, et al.. (1982). Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 9(2). 89–92. 6 indexed citations
7.
Paul, Christer, L. Engstedt, Robert Hast, et al.. (1981). Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia. Cancer Chemotherapy and Pharmacology. 6(1). 65–73. 13 indexed citations
8.
Hast, Robert, L. Engstedt, Sean C. Jameson, et al.. (1978). Oxymetholone treatment in myelofibrosis. Annals of Hematology. 37(1). 19–26. 30 indexed citations
9.
Bratteby, L.‐E., et al.. (1978). Total Body Haemoglobin Estimated with the Alveolar CO Method as Compared with a51Cr Technique. Upsala Journal of Medical Sciences. 83(1). 7–16. 1 indexed citations
10.
Udén, A.‐M., G. Brenning, L. Engstedt, et al.. (1975). L‐Asparaginase and Prednisolone Pretreatment Followed by Rubidomycin and Cytosine Arabinoside for Induction of Remission in Adult Patients with Acute Myeloblastic Leukaemia. Scandinavian Journal of Haematology. 15(1). 72–80. 11 indexed citations
11.
Wadman, B., et al.. (1973). PREGNANCY AND DIABETIC RETINOPATHY. Acta Ophthalmologica. 51(S120). 66–67. 1 indexed citations
12.
Wadman, B., et al.. (1972). Erythrocyte-DPG and Creatine in Polycythemia. New England Journal of Medicine. 287(1). 45–46. 4 indexed citations
13.
Wadman, B. & Ivar Werner. (1972). THROMBOEMBOLIC COMPLICATIONS DURING CORTICOSTEROID TREATMENT OF TEMPORAL ARTERITIS. The Lancet. 299(7756). 907–907. 15 indexed citations
14.
Jameson, S., A. Killander, & B. Wadman. (1971). Iron deficiency anaemia and ‘normal’ bone marrow haemosiderin. Annals of Hematology. 23(2). 61–68. 2 indexed citations
15.
Wadman, B., Edwin S. Spencer, & Ivar Werner. (1971). LIVER CIRRHOSIS IN THREE SCANDINAVIAN COMMUNITIES. Acta Medica Scandinavica. 189(1-6). 221–230. 2 indexed citations
16.
Bratteby, Lars‐Eric, Lars Garby, Torgny Groth, Werner Schneider, & B. Wadman. (1968). STUDIES ON ERYTHRO‐KINETICS IN INFANCY:XIII. The mean Life Span and the Life Span Frequency Function of Red Blood Cells Formed during Foetal Life. Acta Paediatrica. 57(4). 311–320. 46 indexed citations
17.
Bratteby, L.‐E. & B. Wadman. (1968). Labelling of Red Blood Cells in Vitro with Small Amounts of Di-Iso-Propyl-Fluorphosphonate (DF32P). Scandinavian Journal of Clinical and Laboratory Investigation. 21(3). 197–201. 4 indexed citations
18.
Bratteby, Lars‐Eric, Lars Garby, & B. Wadman. (1968). STUDIES ON ERYTHRO‐KINETICS IN INFANCY:XII. Survival in Adult Recipients of Cord Blood Red Cells Labelled in Vitro with Di‐isopropyl fluorophosphonate (DF32P). Acta Paediatrica. 57(4). 305–310. 12 indexed citations
19.
Wadman, B. & Ivar Werner. (1967). THERAPEUTIC HAZARDS OF PHENYLBUTAZONE AND OXYPHENBUTAZONE IN POLYMYALGIA RHEUMATICA. The Lancet. 289(7490). 597–598. 18 indexed citations
20.
Bratteby, L.‐E. & B. Wadman. (1967). Age Distribution and Life Span of Foetal Red Blood Cells Present at Birth. Acta Paediatrica. 56(s177). 97–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by P. D. Roberts Breakdown of academic impact, for papers by S. C. Tso Breakdown of academic impact, for papers by Sheryl R. Simon Breakdown of academic impact, for papers by Franco Capra Breakdown of academic impact, for papers by Barry G. Firkin Breakdown of academic impact, for papers by Irving B. Mink Breakdown of academic impact, for papers by Karin L. G. Svenson Breakdown of academic impact, for papers by E. Cutz Breakdown of academic impact, for papers by Michel-Henry Mendler Breakdown of academic impact, for papers by Pamela B. Sylvestre
Rankless by CCL
2026